TY - JOUR
KW - Adult
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Female
KW - Health Services Accessibility/statistics & numerical data
KW - Humans
KW - Male
KW - Opioid-Related Disorders/drug therapy
KW - Retention in Care/statistics & numerical data
KW - Retrospective Studies
KW - Treatment Outcome
KW - Young Adult
KW - buprenorphine
KW - Health Services Accessibility
KW - opioid-related disorders
KW - Public Health
AU - M. Tierney
AU - K. Melino
AU - A. Adeniji
AU - M. Shumway
AU - I. E. Allen
AU - C. M. Waters
A1 - 
AB - INTRODUCTION: There is considerable need for effective and accessible treatment for opioid use disorder. AIMS: Our study explored differences in buprenorphine treatment retention and duration, with a focus on selected sociodemographic factors and treatment indicators, in two different settings: an office-based buprenorphine induction and stabilization clinic (OBIC) and a community-based primary care clinic (CPC). METHOD: This nonexperimental retrospective chart review compared demographic information and buprenorphine treatment details, including treatment retention and duration. RESULTS: There were no statistically significant differences in buprenorphine treatment indicators between the OBIC and CPC groups, with two exceptions: the number of written buprenorphine prescriptions was significantly greater for the OBIC group, as was the number of filled buprenorphine prescriptions. CONCLUSIONS: Given similar treatment retention and duration in two different buprenorphine treatment settings, our findings suggest that access to buprenorphine treatment in standard integrated care settings can be supplemented by novel treatment structures such as the OBIC in order to increase access to care during the current opioid epidemic.
AD - 1 Matthew Tierney, RN, MS, ANP-BC, PMHNP-BC, University of California, San Francisco, CA, USA.; 2 Katerina Melino, RN, MS, PMHNP-BC, University of California, San Francisco, CA, USA.; 3 Adebowale Adeniji, RN, PMHNP, MSPH, Community Mental Health Nurse, San Mateo County, Daly City, CA, USA.; 4 Martha Shumway, PhD, University of California, San Francisco, CA, USA; Zuckerberg San Francisco General Hospital, San Francisco, CA, USA.; 5 Isabel E. Allen, PhD, University of California, San Francisco, CA, USA.; 6 Catherine M. Waters, RN, PhD, FAAN, University of California, San Francisco, CA, USA.
BT - Journal of the American Psychiatric Nurses Association
C5 - Education & Workforce; Opioids & Substance Use
CP - 4
CY - United States
DO - 10.1177/1078390318805562
IS - 4
JF - Journal of the American Psychiatric Nurses Association
LA - eng
M1 - Journal Article
N2 - INTRODUCTION: There is considerable need for effective and accessible treatment for opioid use disorder. AIMS: Our study explored differences in buprenorphine treatment retention and duration, with a focus on selected sociodemographic factors and treatment indicators, in two different settings: an office-based buprenorphine induction and stabilization clinic (OBIC) and a community-based primary care clinic (CPC). METHOD: This nonexperimental retrospective chart review compared demographic information and buprenorphine treatment details, including treatment retention and duration. RESULTS: There were no statistically significant differences in buprenorphine treatment indicators between the OBIC and CPC groups, with two exceptions: the number of written buprenorphine prescriptions was significantly greater for the OBIC group, as was the number of filled buprenorphine prescriptions. CONCLUSIONS: Given similar treatment retention and duration in two different buprenorphine treatment settings, our findings suggest that access to buprenorphine treatment in standard integrated care settings can be supplemented by novel treatment structures such as the OBIC in order to increase access to care during the current opioid epidemic.
PP - United States
PY - 2019
SN - 1532-5725; 1078-3903
SP - 305
EP - 313
EP - 
T1 - Two Different Buprenorphine Treatment Settings With Similar Retention Rates: Implications for Expanding Access to Treatment for Opioid Use Disorder
T2 - Journal of the American Psychiatric Nurses Association
TI - Two Different Buprenorphine Treatment Settings With Similar Retention Rates: Implications for Expanding Access to Treatment for Opioid Use Disorder
U1 - Education & Workforce; Opioids & Substance Use
U2 - 30295107
U3 - 10.1177/1078390318805562
VL - 25
VO - 1532-5725; 1078-3903
Y1 - 2019
Y2 - Jul/Aug
ER -